Autolus Therapeutics

London, United Kingdomautolus.com1expert edge

Early commercial-stage biopharmaceutical company developing autologous T cell and CAR-T therapies for cancer and autoimmune diseases, with manufacturing facility in Stevenage, UK and European marketing authorization for AUCATZYL.

Why interesting to a deal team

Akinrinsola's advisory role on BioNTech CAR-T collaboration shows expertise in advanced therapy manufacturing; emerging biotech customer profile validates CDMO services expansion into cell therapies.

Experts connected to this company

Israel AkinrinsolaAdvised Autolus on BioNTech CAR-T collaboration

Israel Akinrinsola

Managing Director, Healthcare Strategic Advisory

Evercore

BankerLondon

London-based Evercore healthcare banker with a live track record on pharma services, CDMO capacity, and specialty pharma carve-outs across Europe's largest 2019-2024 deals.

Sources

Name + firmPrimaryArchived 2026-07-26
autolus.com
Page titlePrimary
autolus.gcs-web.com/news-releases/news-release-details/biontech-and-autolus-announce-strategic-car-t-cell-therapy

Strongest evidencePage title2 public sourcesHow the grades work